COVID-19 has impacted the clinical trial landscape dramatically. In this interview with Applied Clinical Trials, John Potthoff discusses how Elligo’s tech-enabled solutions prepared sponsors and physicians to move to decentralized or hybrid trials during COVID-19 and how these solutions could affect the future of clinical trials.

When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us